The government budget appropriations or outlays for R&D in health in the US are projected to rise steadily from 2024 to 2028. Starting at $128.69 billion in 2024, the forecast indicates continuous growth, reaching $144.12 billion by 2028. This reflects a consistent year-on-year increase, averaging a Compound Annual Growth Rate (CAGR) of approximately 2.85% over the forecast period.

Future trends to watch for:

Advancements in biotechnology and pharmaceuticals may drive increased R&D investments.
Government priorities on pandemic preparedness could further impact budget allocations.
Political and economic factors influencing federal budgets could alter long-term forecasts.